FDA Approves Roche's HPV Self-Testing Kit on Wednesday, Including Self-Collection

May 15, 2024, 09:30 AM

Swiss drugmaker Roche announced on Wednesday that the US Food and Drug Administration (FDA) has approved its human papillomavirus (HPV) self-testing kit. The self-sampling solution aims to address unequal access to screening that can put women at risk of cervical cancer. This approval provides an alternative to the traditional pelvic exam, potentially making it easier for women of color and those in rural and underserved communities to screen for HPV. The method involves self-collection for virus screening.